The Lancet Microbe in conversation with

Editors at The Lancet Microbe, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from using probiotics to reduce Staphylococcus aureus, to phage therapy and monitoring antimicrobial resistance using faecal metagenomes, and more.

The Lancet Microbe in conversation with is a health podcast hosted by Unknown Host, with 27 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Unknown Host hosts The Lancet Microbe in conversation with, a health show with 27 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #5

  Luria Leslie Founou on neonatal sepsis in Africa

  Aug 12, 202623 min

  Phoebe Ashley-Norman talks with Luria Leslie Founou about neonatal sepsis in Cameroon and sub-Saharan Africa more broadly, in conversation around the Lancet Microbe Personal View "Neonatal sepsis in Africa: what are we missing" Read the Personal View here: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(26)00029-7/fulltext Dr Founou is a microbiologist and researcher with a focus on antimicrobial resistance and infectious diseases. She is also Founder and CEO of D2Africa (Dare to Dream for Africa), which can be found on YouTube at Dare to Dream for Africa - YouTube . D2Africa Stories is her podcast, where she shares the stories of inspiring African scientists and change-makers, available here D2AFRICA Stories - YouTube .

  ListenShow Notes
• 

  Episode #3

  Henriette Nielsen on vaginal microbiota transplantation

  May 25, 202617 minS0

  <p>Elisa Pucu speaks with Henriette Svarre Nielsen about their recently published randomised controlled trial, “Vaginal microbiota transplantation for treatment of vaginal dysbiosis without the use of antibiotics: a double-blind, randomised controlled trial in women with vaginal dysbiosis.”</p> <p>Together, they explore the study’s key findings, its implications for women’s health, and the growing importance of vaginal microbiota transplantation as a research frontier. They also reflect on what lies ahead for this emerging field.</p> <p>https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00222-8/fulltext</p>

  ListenShow Notes
• 

  Episode #2

  Zakiul Hassan and Tahmina Shirin on Nipah virus disease

  Apr 13, 202637 minS0

  <p>Phoebe Ashley-Norman talks with Zakiul Hassan and Prof Tahmina Shirin about the findings of "Interpreting the natural history and pathogenesis of Nipah virus disease through clinical data, to inform clinical trial design: a systematic review", by Zakiul Hassan and colleagues.</p> <p>We also discuss Nipah virus disease more broadly, talking about recent phylogenetic findings, diagnostics, therapeutics, vaccines, and ongoing challenges.</p> <p>Read the systematic review here: https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00223-X/fulltext </p> <p>We also touched on some past Lancet publications, which you can explore here: https://www.thelancet.com/journals...

  ListenShow Notes
• 

  The Lancet Microbe in conversation with

  Claas Kirchhelle and Lloyd Czaplewski on AMR governance and financing

  Mar 5, 202637 minS0

  <p>Elena Dalla Vecchia talks with Claas Kirchhelle and Lloyd Czaplewski about the current antimicrobial resistance (AMR) governance (with a historical perspective on how it came to be), the 2015 WHO Global Action Plan (GAP) on AMR and the draft for the 2026 updated GAP, the role of social sciences in addressing AMR, the financing mechanisms in antibiotic research and development (including push and pull incentives with public and philantropic funding), and perspectives on the future of the fight against AMR. </p> <p>Click here to read the full article:</p> <p><b>https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00243...

  ListenShow Notes
• 

  The Lancet Microbe in conversation with

  Magnus Unemo on Zoliflodacin treatment for gonorrhea

  Feb 5, 202616 minS0

  <p>Elisa Pucu from The Lancet Microbe interviews Dr. Magnus Unemo of Örebro University about the clinical implications and key findings from his research. They discuss about the the microbiological analysis and whole genome sequencing of treatment failures from the zoliflodacin phase 3 clinical trial for gonorrhea—revealing insights that could change the future of treatment and antibiotic resistance. </p> <p>Click here to read the full articles: <b>https://www.thelancet.com/journals/lanmic/article/PIIS2666-5247(25)00198-3/fulltext</b></p> <p><b>https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01953-1/fulltext</b></p> <p>Continue this conversation on s...

  ListenShow Notes

Recent guests on The Lancet Microbe in conversation with. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.